SCHEMBL15910239

SCHEMBL15910239

CC(C)(C)c1ccc2c(c1)c1cc(C(C)(C)C)ccc1n2-c1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 12/20 0.72
AHR P35869 1/20 0.42
KDM4E B2RXH2 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRA6 Q16445 1/20 0.39
GPR3 P46089 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22514643 0.93 KIF11 (0.65) KIF11AHRKDM4EKMT2AALDH1A1
SCHEMBL30451263 0.93 KIF11 (0.58) KIF11KMT2AMEN1GABRA1GABRG2
SCHEMBL15910226 0.93 KIF11 (0.58) KIF11KMT2AMEN1GABRA1GABRG2
SCHEMBL23050967 0.92 KIF11 (0.68) KIF11AHRALDH1A1HSD17B10GPR3
SCHEMBL263281 0.90 KIF11 (0.65) KIF11AHRKDM4EKMT2AALDH1A1
SCHEMBL14679754 0.89 KIF11 (0.56) KIF11KDM4EHPGDGABRA1GABRG2
SCHEMBL263162 0.87 KIF11 (0.65) KIF11AHRKDM4EKMT2AALDH1A1
SCHEMBL14679719 0.86 KIF11 (0.53) KIF11AHRKDM4EKMT2AALDH1A1
SCHEMBL30631029 0.85 AHR (0.50) KIF11AHRKDM4EKMT2AALDH1A1
SCHEMBL24985939 0.85 AHR (0.50) KIF11AHRKDM4EKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109053680-B Organic small-molecule photoelectric functional material based on 3-benzoylpyridine as receptor unit, and preparation method and application thereof 华南理工大学 2020-07-28 CN claimed
US-20210066620-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-03-04 US disclosed
CN-109053680-B Organic small-molecule photoelectric functional material based on 3-benzoylpyridine as receptor unit, and preparation method and application thereof 华南理工大学 2020-07-28 CN disclosed
EP-2949724-B1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME KYULUX INC (JP) 2020-06-17 EP disclosed
EP-2949724-B1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME KYULUX INC (JP) 2020-06-17 EP disclosed
US-20150357582-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING DEVICE USING SAME KYULUX, INC. (JP) 2015-12-10 US disclosed
EP-2949724-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME Kyushu University, National University Corporation (JP) 2015-12-02 EP disclosed
EP-2949724-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME Kyushu University, National University Corporation (JP) 2015-12-02 EP disclosed
WO-2014115743-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME 国立大学法人九州大学 (JP) 2014-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150357582-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, INTS9 KIF11 3686/4885AHR 451/4885KDM4E 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.